Checked 2026-11-10. Independent clinical review has not been completed. WADAFUK is independent of WADA and does not provide medical advice or an individual anti-doping determination.
Conditional restriction
WADA 2026: S6.B, prohibited in competition except qualifying local administration, including the listed nasal, ophthalmic and local-anesthetic contexts. This is not a general exception for every epinephrine product. The future 2027 List retains the wording. [1] [2]
2026 and 2027 List, S6.B, printed pp.15–16; introductory definitions p.3 · 2026 rules apply from 1 January 2026. Any 2027 material below concerns future rules from 1 January 2027; it is not current clearance.
Emergency allergy treatment
The reviewed US neffy label describes an epinephrine nasal spray for emergency allergic reactions including anaphylaxis. The product’s emergency systemic purpose means that its nasal route alone should not be treated as a verified interpretation of WADA’s local-administration exception. [3]
- Whether a specific systemic-purpose nasal product falls within that exception was not resolved here. Do not delay prescribed emergency treatment; obtain case-specific anti-doping advice.
What remains uncertain
- Educational synthesis only; not individualized medical advice, a TUE decision or a sanction prediction.
Check the sources.
These are concise editorial paraphrases of selected sources, not a systematic review or a reproduction of source tables. Access depth is shown for each reference; an abstract-only check cannot resolve details found only in a full paper.
- WADA 2026 Prohibited List ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected
Introduction p.3 · S6 pp.15–16
- WADA 2027 Prohibited List, 4 November revision ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected · FUTURE 2027 SOURCE
Introduction p.3 · S6 pp.15–16
- M13. DailyMed. Neffy epinephrine nasal-spray label, revised March 2026 / updated April 2026, including systemic exposure and anaphylaxis indication. ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected
Indications; clinical pharmacology
Check the current official WADA List and the relevant anti-doping authority for your sport, product, route and circumstances. Do not stop or change necessary treatment based on this page. Ask a qualified clinician about health decisions. Missing evidence does not establish safety.